Topica initiates enrollment in Phase II study of antifungal drug
Topica Pharmaceuticals has initiated patient enrollment in a Phase II clinical trial evaluating luliconazole for the treatment of tinea pedis. The Phase II, multi-center, randomized, double-blind trial is
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.